Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- NEW PRODUCTS
July 29, 2002
- Tanabe Aims at World-class Performance for Each Division: President Hayama
July 29, 2002
- FY2003 Budget Formation Schedule Confirmed
July 29, 2002
- US Consumers Appreciate Online Healthcare Information: PhRMA Seminar
July 29, 2002
- REGULATORY NEWS IN BRIEF
July 29, 2002
- 15th Interphex Japan
July 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 29, 2002
- Nippon Chemiphar to Beef Up Its Generic Business
July 29, 2002
- Asahi Kasei to Look For Lead Compounds with SGX
July 29, 2002
- Promoting GE Use Needs Various Means: Mr Wright of EFPIA
July 29, 2002
- MPC-backed New Foundation Invites Applications for CV Research Grants
July 29, 2002
- Takeda to Expand Lineup of Antidiabetic Drugs
July 29, 2002
- Kuraya Sanseido Acquires ATOL's Business in Tokyo, Kanagawa
July 22, 2002
- Sankyo Pharma to Market Cygnus' GlucoWatch
July 22, 2002
- MOSS Institute to Be Listed on August 8
July 22, 2002
- Shionogi-GSK Announces 1st Clinical Trial Results for New Anti-HIV Drug
July 22, 2002
- Number of Wholesalers to Decrease to 3 to 40 by 2011: YRI Report
July 22, 2002
- First Study on Palliative Medicine in Japan Completed
July 22, 2002
- Monkasho Holds Symposium on National Bioresources Project
July 22, 2002
- WORLD NEWS IN BRIEF
July 22, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…